Low RNA disruption during neoadjuvant chemotherapy predicts pathologic complete response absence in patients with breast cancer

  1. Cazzaniga, M.E.
  2. Ademuyiwa, F.
  3. Petit, T.
  4. Tio, J.
  5. Generali, D.
  6. Ciruelos, E.M.
  7. Califaretti, N.
  8. Poirier, B.
  9. Ardizzoia, A.
  10. Dr Med, A.H.
  11. Dr Med, B.L.
  12. Mouret-Reynier, M.-A.
  13. Dr Med, D.G.
  14. Isambert, N.
  15. Masetti, R.
  16. Pitre, L.
  17. Dr Med, D.W.
  18. Augereau, P.
  19. Milani, M.
  20. Rask, S.
  21. Dr Med, C.S.
  22. Pritzker, L.
  23. Noubir, S.
  24. Parissenti, A.
  25. Trudeau, M.E.
Revue:
JNCI Cancer Spectrum

ISSN: 2515-5091

Année de publication: 2024

Volumen: 8

Número: 1

Type: Article

DOI: 10.1093/JNCICS/PKAD107 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus